scholarly journals CIED guideline recommendations in the setting of advisories

2021 ◽  
Author(s):  
Michael Sawyer ◽  
Paul Gould
Keyword(s):  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Electronic Device ◽  
Implantable Cardioverter Defibrillators ◽  
Cardiac Implantable Electronic Device ◽  
Icd Implantation ◽  
Cardioverter Defibrillators

Subcutaneous implantable cardioverter defibrillators (S-ICDs) are currently indicated for patients who meet ICD implantation criteria for the prevention of sudden cardiac death (SCD). In December 2020, a unique cardiac implantable electronic device (CIED) situation arose as both the S-ICD generator and electrode were under a device advisory. We would recommend all future CIED implantation guidelines receive a caveat regarding checking current CIED advisories, in order to avoid future similar scenarios.

The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome

2019 ◽  
Vol 41 (21) ◽  
pp. 2003-2011 ◽  
Author(s):  
Ilan Goldenberg ◽  
David T Huang ◽  
Jens Cosedis Nielsen
Keyword(s):  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Current Knowledge ◽  
Left Ventricular ◽  
Cardiac Resynchronization ◽  
Implantable Cardioverter Defibrillators ◽  
Icd Implantation ◽  
Device Selection ◽  
Cardioverter Defibrillators

Abstract Multiple randomized multicentre clinical trials have established the role of the implantable cardioverter-defibrillator (ICD) as the mainstay in the treatment of ventricular tachyarrhythmias and sudden cardiac death (SCD) prevention. These trials have focused mainly on heart failure patients with advanced left ventricular dysfunction and were mostly conducted two decades ago, whereas a more recent trial has provided conflicting results. Therefore, much remains to be determined on how best to balance the identification of patients at high risk of SCD together with who would benefit most from ICD implantation in a contemporary setting. Implantable cardioverter-defibrillators have also evolved from the simple, defibrillation-only devices implanted surgically to more advanced technologies of multi-chamber devices, with physiologic bradycardic pacing, including cardiac resynchronization therapy, atrial and ventricular therapeutic pacing algorithms, and subcutaneous ICDs. These multiple options necessitate individualized approach to device selection and programming. This review will focus on the current knowledge on selection of patients for ICD treatment, device selection and programming, and future directions of implantable device therapy for SCD prevention.

scholarly journals Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients

Circulation ◽  
2019 ◽  
Vol 139 (23) ◽  
pp. 2628-2638 ◽  
Author(s):  
J. Wouter Jukema ◽  
Rohit J. Timal ◽  
Joris I. Rotmans ◽  
Liselotte C. R. Hensen ◽  
Maurits S. Buiten ◽  
...  
Keyword(s):  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Implantable Cardioverter Defibrillators ◽  
Dialysis Patients ◽  
Prophylactic Use ◽  
Cardioverter Defibrillators

scholarly journals Modern pacemaker therapy

2010 ◽  
Vol 63 (11-12) ◽  
pp. 822-826
Author(s):  
Dragan Kovacevic ◽  
Vasilije Topalov ◽  
Milan Mijatov
Keyword(s):  
Heart Failure ◽  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Modern Medicine ◽  
Implantable Cardioverter Defibrillators ◽  
Bundle Branch Block ◽  
Pacemaker Therapy ◽  
Patients With Heart Failure ◽  
Cardioverter Defibrillators

Introduction. Pacemakers are devices that modern medicine and cardiology cannot be imagined without. The technique of implantation comes to surgical procedure where all principles of asepsis and antisepsis have to be respected. Although some complications do happen, they are rather rare. Results. After the implantation of the device, the patient is not handicapped (unless the heart was additionally damaged). On the contrary, the patient returns to his work and functions normally within his family in most of the cases. The first medical appointment is scheduled a month after the implantation and the following are three and six months after. Types of devices. Today there are ?new types of electrostimulation?- implantable cardioverter defibrillators and multisite electrostimulators. The former is implanted in patients at high risk of sudden cardiac death and the latter in patients with heart failure and left bundle branch block. Owing to these devices, the sudden cardiac death can be prevented successfully and the quality of a patient?s life is improved.

Sign in / Sign up

Export Citation Format

Share Document